PL2839829T3 - Tabletka o przedłużonym uwalnianiu zawierająca lewodropropizynę i sposób jej wytwarzania - Google Patents
Tabletka o przedłużonym uwalnianiu zawierająca lewodropropizynę i sposób jej wytwarzaniaInfo
- Publication number
- PL2839829T3 PL2839829T3 PL13778634T PL13778634T PL2839829T3 PL 2839829 T3 PL2839829 T3 PL 2839829T3 PL 13778634 T PL13778634 T PL 13778634T PL 13778634 T PL13778634 T PL 13778634T PL 2839829 T3 PL2839829 T3 PL 2839829T3
- Authority
- PL
- Poland
- Prior art keywords
- sustained release
- release tablet
- tablet containing
- preparing same
- levodropropizine
- Prior art date
Links
- PTVWPYVOOKLBCG-ZDUSSCGKSA-N levodropropizine Chemical compound C1CN(C[C@H](O)CO)CCN1C1=CC=CC=C1 PTVWPYVOOKLBCG-ZDUSSCGKSA-N 0.000 title 1
- 229960002265 levodropropizine Drugs 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000007939 sustained release tablet Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2121/00—Preparations for use in therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020120039907A KR20130117128A (ko) | 2012-04-17 | 2012-04-17 | 레보드로프로피진 함유 서방정 및 이의 제조방법 |
| EP13778634.9A EP2839829B1 (en) | 2012-04-17 | 2013-04-17 | Sustained release tablet containing levodropropizine and method for preparing same |
| PCT/KR2013/003232 WO2013157841A1 (ko) | 2012-04-17 | 2013-04-17 | 레보드로프로피진 함유 서방정 및 이의 제조방법 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2839829T3 true PL2839829T3 (pl) | 2019-03-29 |
Family
ID=49383726
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL13778634T PL2839829T3 (pl) | 2012-04-17 | 2013-04-17 | Tabletka o przedłużonym uwalnianiu zawierająca lewodropropizynę i sposób jej wytwarzania |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP2839829B1 (pl) |
| KR (1) | KR20130117128A (pl) |
| BR (1) | BR112014026040B1 (pl) |
| ES (1) | ES2693156T3 (pl) |
| PH (1) | PH12014502325A1 (pl) |
| PL (1) | PL2839829T3 (pl) |
| RU (1) | RU2616263C2 (pl) |
| WO (1) | WO2013157841A1 (pl) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102260235B1 (ko) * | 2018-09-10 | 2021-06-03 | 콜마파마 주식회사 | 레보드로프로피진 방출제어형 이층정제 및 이의 제조방법 |
| KR102246066B1 (ko) * | 2019-02-12 | 2021-04-29 | 한국유나이티드제약 주식회사 | 레보드로프로피진 함유 서방정의 제조방법 |
| CN110934872B (zh) * | 2019-12-16 | 2023-01-10 | 太阳升(亳州)生物医药科技有限公司 | 左羟愈酚胶囊及其制备方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002350719A1 (en) * | 2002-11-29 | 2004-06-23 | Janssen Pharmaceutica N.V. | Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water-soluble acid respectively base |
| KR101050076B1 (ko) * | 2009-02-04 | 2011-07-19 | 한국유나이티드제약 주식회사 | 제어 방출성 아세클로페낙을 함유하는 경구 제제의 조성물 및 그의 제조방법 |
| KR101246553B1 (ko) | 2010-04-09 | 2013-03-26 | 현대약품 주식회사 | 서방성 약제학적 조성물 및 이의 제조방법 |
| KR101272470B1 (ko) * | 2010-09-30 | 2013-06-14 | 주식회사 바이오파마티스 | 레보드로프로피진을 포함하는 속효성과 지속성을 동시에 갖는 약제학적 조성물 |
| WO2011126327A2 (en) * | 2010-04-09 | 2011-10-13 | Hyundai Pharm Co., Ltd. | Pharmaceutical composition with controlled-release properties comprising mosapride or levodropropizine, and preparing method thereof |
| KR101234254B1 (ko) * | 2010-06-01 | 2013-02-18 | 한국유나이티드제약 주식회사 | 1일 1회 투여로 최적의 약리학적 임상 효과를 제공하는 아세클로페낙 서방성 제제 |
-
2012
- 2012-04-17 KR KR1020120039907A patent/KR20130117128A/ko not_active Ceased
-
2013
- 2013-04-17 EP EP13778634.9A patent/EP2839829B1/en active Active
- 2013-04-17 ES ES13778634.9T patent/ES2693156T3/es active Active
- 2013-04-17 PL PL13778634T patent/PL2839829T3/pl unknown
- 2013-04-17 WO PCT/KR2013/003232 patent/WO2013157841A1/ko not_active Ceased
- 2013-04-17 RU RU2014145845A patent/RU2616263C2/ru active
- 2013-04-17 BR BR112014026040-0A patent/BR112014026040B1/pt active IP Right Grant
-
2014
- 2014-10-17 PH PH12014502325A patent/PH12014502325A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2839829A4 (en) | 2015-02-25 |
| BR112014026040B1 (pt) | 2022-02-22 |
| KR20130117128A (ko) | 2013-10-25 |
| BR112014026040A2 (pt) | 2017-06-27 |
| EP2839829B1 (en) | 2018-09-26 |
| WO2013157841A1 (ko) | 2013-10-24 |
| PH12014502325B1 (en) | 2015-01-12 |
| EP2839829A1 (en) | 2015-02-25 |
| RU2014145845A (ru) | 2016-06-10 |
| ES2693156T3 (es) | 2018-12-07 |
| RU2616263C2 (ru) | 2017-04-13 |
| PH12014502325A1 (en) | 2015-01-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL235826A (en) | Diazaspirocycloalkanes and thenaspirocycloalkanes and their preparation | |
| EP2875959A4 (en) | PRINTING MACHINE AND TABLET ASSOCIATED | |
| EP2923138A4 (en) | SAFETY SYSTEM FOR DISPLAYING OBJECTS | |
| GB2504463B (en) | Support product | |
| SG11201500292SA (en) | Pill crushing system | |
| EP2862099A4 (en) | SYSTEMS AND METHODS FOR CHANGING ASYNCHRONOUS DIAGRAMS | |
| PL2617302T3 (pl) | Sposób i zespół do przekazywania kapsułek | |
| IL236614A0 (en) | A foamable item | |
| EP2897083A4 (en) | ARTICLE MANAGEMENT SYSTEM | |
| PT2864113T (pt) | Prensa de comprimido | |
| EP2934412A4 (en) | LAMINATE AND METHOD FOR THE MANUFACTURE THEREOF | |
| SG11201500119QA (en) | Deluge system | |
| SG11201500746YA (en) | System and method for geothentication | |
| GB2497150B (en) | Storage apparatus | |
| GB201218084D0 (en) | Novel compounds and methods for use in medicine | |
| GB2502402B (en) | Controlled drug release | |
| SG11201504844SA (en) | Medical tablet, and manufacturing method and manufacturing apparatus for medical tablet | |
| GB201202093D0 (en) | Drug storage apparatus | |
| AP2015008268A0 (en) | Rolling container system | |
| GB201214978D0 (en) | Multiple-mobile-computer storage apparatus | |
| GB2500046B (en) | Storage apparatus | |
| GB201213778D0 (en) | Process and dressng | |
| PT2668839T (pt) | Sistema de trituração | |
| PL398018A1 (pl) | Nowa diacylo-sn-glicero-3-fosfocholina oraz sposób jej otrzymywania | |
| PL398021A1 (pl) | Nowa diacylo-sn-glicero-3-fosfocholina oraz sposób jej otrzymywania |